Nuvectis Pharma Inc.
5.46
-0.18 (-3.19%)
At close: Jan 15, 2025, 3:59 PM
5.37
-1.65%
After-hours Jan 15, 2025, 04:00 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20
PE Ratio -5.83 -5.05 -3.21 -4.13K
PS Ratio n/a 637.13 n/a n/a
PB Ratio 10.63 6.68 -3.75 -4.13K
P/FCF Ratio -8.13 -7 -4.35 1.72K
P/OCF Ratio -8.13 -7 -4.35 1.72K
OCF/S Ratio n/a -91 n/a n/a
Debt / Equity Ratio n/a n/a n/a n/a
Quick Ratio 2.75 3.30 2.41 n/a
Current Ratio 2.75 3.30 2.41 n/a
Asset Turnover n/a 0.01 n/a n/a
Interest Coverage n/a -129.09 n/a n/a
Return on Equity (ROE) -1.82 -1.32 1.17 1.00
Return on Assets (ROA) -1.16 -0.92 -1.94 n/a
Return on Capital (ROIC) -1.88 -1.35 -3.04 1.00
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a -12.81K% n/a n/a
Net Profit Margin n/a -12.61K% n/a n/a
Pretax Profit Margin n/a -12.81K% n/a n/a
Operating Profit Margin n/a -12.91K% n/a n/a
FCF Margin n/a -9.10K% n/a n/a
EBITDA Margin n/a -12.91K% n/a n/a